Join Quita Beeler Highsmith, VP and Chief Diversity Officer, for a conversation on Genentech’s Diversity and Inclusion strategy, which includes recruiting, retaining & developing diverse talent, addressing barriers in clinical trial participation, and promoting patient inclusion. In 2020, Quita was named one of the 100 Most Influential Women in Business by the San Francisco Business Times and Top 50 Chief Diversity Officers by The National Diversity Council.
Considered the founder of the biotechnology industry, Genentech has been developing groundbreaking medicine for people with life-threatening diseases for over 40 years. Their discoveries include the first targeted antibody for cancer and first medicine for primary progressive multiple sclerosis.
About the DE&I Next Practices Monthly Series
The DE&I Next Practices Monthly series provides a forum for the DE&I leadership community to come together to discover and advance next practices. Each month, you’ll hear from Diversity, Equity, and Inclusion Leaders from some of the largest and most respected organizations in the world, learn about the latest i4cp research, and share and receive ideas from your peers.
Based on the latest thinking from i4cp’s Chief Diversity Officer Board, these monthly calls are not webinars – they are open meetings – and are designed to help you navigate the next normal.